Exact Mass: 664.4914

Exact Mass Matches: 664.4914

Found 95 metabolites which its exact mass value is equals to given mass value 664.4914, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

DG(16:0/PGE2/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl hexadecanoic acid

C39H68O8 (664.4914)

DG(16:0/PGE2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/PGE2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGE2/16:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propan-2-yl hexadecanoic acid

C39H68O8 (664.4914)

DG(PGE2/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGE2/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(16:0/0:0/PGE2)

(2R)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl hexadecanoic acid

C39H68O8 (664.4914)

DG(16:0/0:0/PGE2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGE2/0:0/16:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl hexadecanoic acid

C39H68O8 (664.4914)

DG(PGE2/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(16:0/PGD2/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl hexadecanoic acid

C39H68O8 (664.4914)

DG(16:0/PGD2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/PGD2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGD2/16:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propan-2-yl hexadecanoic acid

C39H68O8 (664.4914)

DG(PGD2/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGD2/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(16:0/0:0/PGD2)

(2R)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl hexadecanoic acid

C39H68O8 (664.4914)

DG(16:0/0:0/PGD2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGD2/0:0/16:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl hexadecanoic acid

C39H68O8 (664.4914)

DG(PGD2/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(16:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

(2S)-1-(Hexadecanoyloxy)-3-hydroxypropan-2-yl (5S,6S,7E,9E,11Z,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid

C39H68O8 (664.4914)

DG(16:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/16:0/0:0)

(2S)-2-(Hexadecanoyloxy)-3-hydroxypropyl (5R,6R,7E,9E,11Z,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid

C39H68O8 (664.4914)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(16:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

(2R)-3-(hexadecanoyloxy)-2-hydroxypropyl (5R,6R,7E,9E,11Z,13E,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

C39H68O8 (664.4914)

DG(16:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/16:0)

(2S)-3-(hexadecanoyloxy)-2-hydroxypropyl (5R,6R,7E,9E,11Z,13E,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

C39H68O8 (664.4914)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-16:0/PGE2/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl 14-methylpentadecanoic acid

C39H68O8 (664.4914)

DG(i-16:0/PGE2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-16:0/PGE2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGE2/i-16:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propan-2-yl 14-methylpentadecanoic acid

C39H68O8 (664.4914)

DG(PGE2/i-16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGE2/i-16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-16:0/0:0/PGE2)

(2R)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl 14-methylpentadecanoic acid

C39H68O8 (664.4914)

DG(i-16:0/0:0/PGE2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGE2/0:0/i-16:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl 14-methylpentadecanoic acid

C39H68O8 (664.4914)

DG(PGE2/0:0/i-16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-16:0/PGD2/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl 14-methylpentadecanoic acid

C39H68O8 (664.4914)

DG(i-16:0/PGD2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-16:0/PGD2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGD2/i-16:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propan-2-yl 14-methylpentadecanoic acid

C39H68O8 (664.4914)

DG(PGD2/i-16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGD2/i-16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-16:0/0:0/PGD2)

(2R)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl 14-methylpentadecanoic acid

C39H68O8 (664.4914)

DG(i-16:0/0:0/PGD2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGD2/0:0/i-16:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl 14-methylpentadecanoic acid

C39H68O8 (664.4914)

DG(PGD2/0:0/i-16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-16:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

(2S)-1-Hydroxy-3-[(14-methylpentadecanoyl)oxy]propan-2-yl (5S,6S,7E,9E,11Z,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid

C39H68O8 (664.4914)

DG(i-16:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-16:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/i-16:0/0:0)

(2S)-3-hydroxy-2-[(14-methylpentadecanoyl)oxy]propyl (5R,6R,7E,9E,11Z,13E,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

C39H68O8 (664.4914)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/i-16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/i-16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-16:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

(2R)-2-Hydroxy-3-[(14-methylpentadecanoyl)oxy]propyl (5R,6R,7E,9E,11Z,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid

C39H68O8 (664.4914)

DG(i-16:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/i-16:0)

(2S)-2-hydroxy-3-[(14-methylpentadecanoyl)oxy]propyl (5R,6R,7E,9E,11Z,13E,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

C39H68O8 (664.4914)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/i-16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

20,44-Dihydroxy-4,8,14,23,27,42-hexatetracontahexaene-1,18,21,45-tetrayn-3-one|petroformyne-8

C46H64O3 (664.4855)

plagioneurin C

C39H68O8 (664.4914)

Thermoactinoamide_E

C35H64N6O6 (664.4887)

3-[[7alpha-Hydroxy-24-oxo-3beta-[[3-[(4-aminobutyl)amino]propyl]amino]-5alpha-cholestane-26-yl]thio]-2-aminopropanoic acid

C37H68N4O4S (664.4961)

DG(16:0/PGE2/0:0)

C39H68O8 (664.4914)

DG(PGE2/16:0/0:0)

C39H68O8 (664.4914)

DG(16:0/0:0/PGE2)

C39H68O8 (664.4914)

DG(PGE2/0:0/16:0)

C39H68O8 (664.4914)

DG(16:0/PGD2/0:0)

C39H68O8 (664.4914)

DG(PGD2/16:0/0:0)

C39H68O8 (664.4914)

DG(16:0/0:0/PGD2)

C39H68O8 (664.4914)

DG(PGD2/0:0/16:0)

C39H68O8 (664.4914)

DG(i-16:0/PGE2/0:0)

C39H68O8 (664.4914)

DG(PGE2/i-16:0/0:0)

C39H68O8 (664.4914)

DG(i-16:0/0:0/PGE2)

C39H68O8 (664.4914)

DG(PGE2/0:0/i-16:0)

C39H68O8 (664.4914)

DG(i-16:0/PGD2/0:0)

C39H68O8 (664.4914)

DG(PGD2/i-16:0/0:0)

C39H68O8 (664.4914)

DG(i-16:0/0:0/PGD2)

C39H68O8 (664.4914)

DG(PGD2/0:0/i-16:0)

C39H68O8 (664.4914)

DG(16:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

C39H68O8 (664.4914)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/16:0/0:0)

C39H68O8 (664.4914)

DG(16:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C39H68O8 (664.4914)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/16:0)

C39H68O8 (664.4914)

DG(i-16:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

C39H68O8 (664.4914)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/i-16:0/0:0)

C39H68O8 (664.4914)

DG(i-16:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C39H68O8 (664.4914)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/i-16:0)

C39H68O8 (664.4914)

2-[hydroxy-[(2R)-2-nonanoyloxy-3-octadecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

NAOrn 18:5/18:3

C41H64N2O5 (664.4815)

NAOrn 20:5/16:3

C41H64N2O5 (664.4815)

NAOrn 16:4/20:4

C41H64N2O5 (664.4815)

2-[[(2R)-3-dodecanoyloxy-2-pentadecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[hydroxy-[(2R)-2-tetradecanoyloxy-3-tridecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[hydroxy-[(2R)-3-tetradecanoyloxy-2-tridecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[[(2R)-2-dodecanoyloxy-3-pentadecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

[O-(1-O-Undecanoyl-2-O-hexadecanoyl-L-glycero-3-phospho)choline]anion

C35H71NO8P+ (664.4917)

2-[[(2S)-3-hexadecanoyloxy-2-undecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[(3-Decanoyloxy-2-heptadecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[(2-Hexadecanoyloxy-3-undecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[(3-Dodecanoyloxy-2-pentadecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[Hydroxy-(2-tetradecanoyloxy-3-tridecanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[Hydroxy-(2-nonadecanoyloxy-3-octanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[Hydroxy-(3-nonanoyloxy-2-octadecanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[[(2S)-2-decanoyloxy-3-heptadecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[[(2R)-3-decanoyloxy-2-heptadecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[(3-Butanoyloxy-2-tricosanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[(3-Heptanoyloxy-2-icosanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[(2-Docosanoyloxy-3-pentanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[Hydroxy-(3-propanoyloxy-2-tetracosanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[(2-Henicosanoyloxy-3-hexanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[(3-Acetyloxy-2-pentacosanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

(1r)-1-hydroxy-1-[(2r,5r)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]-15-[(5s)-5-methyl-2-oxo-5h-furan-3-yl]-8-oxopentadecan-3-yl acetate

C39H68O8 (664.4914)

1-hydroxy-1-[5-(1-hydroxytridecyl)oxolan-2-yl]-15-(5-methyl-2-oxo-5h-furan-3-yl)-8-oxopentadecan-3-yl acetate

C39H68O8 (664.4914)

(1r,3s)-1-hydroxy-1-[(2r,5r)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]-15-[(5s)-5-methyl-2-oxo-5h-furan-3-yl]-8-oxopentadecan-3-yl acetate

C39H68O8 (664.4914)

3-hydroxy-1-[5-(1-hydroxytridecyl)oxolan-2-yl]-15-(5-methyl-2-oxo-5h-furan-3-yl)-13-oxopentadecyl acetate

C39H68O8 (664.4914)

3-{[(6r)-6-[(1r,3as,3br,4r,5ar,7s,9as,9bs,11ar)-7-({3-[(4-aminobutyl)amino]propyl}amino)-4-hydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-oxoheptyl]sulfanyl}-2-aminopropanoic acid

3-{[(6r)-6-[(1r,3as,3br,4r,5ar,7s,9as,9bs,11ar)-7-({3-[(4-aminobutyl)amino]propyl}amino)-4-hydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-oxoheptyl]sulfanyl}-2-aminopropanoic acid

C37H68N4O4S (664.4961)

(2s,4s,6s,8s,10z,12r,14r,16e,18s,19s)-11,19-dihydroxy-20-{5'-[(1r)-1-hydroxyethyl]-2,5'-dimethyl-[2,2'-bioxolan]-5-yl}-2,4,6,8,12,14,18-heptamethyl-9-oxoicosa-10,16-dienoic acid

C39H68O8 (664.4914)

(1r,3s)-3-hydroxy-1-[(2r,5r)-5-[(1s)-1-hydroxytridecyl]oxolan-2-yl]-15-[(5s)-5-methyl-2-oxo-5h-furan-3-yl]-13-oxopentadecyl acetate

C39H68O8 (664.4914)

(2r)-3-{[(2s,6r)-6-[(1r,3as,3br,4r,5ar,7s,9as,9bs,11ar)-7-({3-[(4-aminobutyl)amino]propyl}amino)-4-hydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-oxoheptyl]sulfanyl}-2-aminopropanoic acid

(2r)-3-{[(2s,6r)-6-[(1r,3as,3br,4r,5ar,7s,9as,9bs,11ar)-7-({3-[(4-aminobutyl)amino]propyl}amino)-4-hydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-oxoheptyl]sulfanyl}-2-aminopropanoic acid

C37H68N4O4S (664.4961)

(4e,8z,14z,23e,27z,42e)-20,44-dihydroxyhexatetraconta-4,8,14,23,27,42-hexaen-1,18,21,45-tetrayn-3-one

C46H64O3 (664.4855)

11,19-dihydroxy-20-[5'-(1-hydroxyethyl)-2,5'-dimethyl-[2,2'-bioxolan]-5-yl]-2,4,6,8,12,14,18-heptamethyl-9-oxoicosa-10,16-dienoic acid

C39H68O8 (664.4914)

(2s,4s,6s,8s,12r,14r,18s,19s)-11,19-dihydroxy-20-{5'-[(1r)-1-hydroxyethyl]-2,5'-dimethyl-[2,2'-bioxolan]-5-yl}-2,4,6,8,12,14,18-heptamethyl-9-oxoicosa-10,16-dienoic acid

C39H68O8 (664.4914)

20,44-dihydroxyhexatetraconta-4,8,14,23,27,42-hexaen-1,18,21,45-tetrayn-3-one

C46H64O3 (664.4855)

(4e,8z,14z,20r,23e,27z,42e,44s)-20,44-dihydroxyhexatetraconta-4,8,14,23,27,42-hexaen-1,18,21,45-tetrayn-3-one

C46H64O3 (664.4855)

2-amino-3-({6-[7-({3-[(4-aminobutyl)amino]propyl}amino)-4-hydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-oxoheptyl}sulfanyl)propanoic acid

C37H68N4O4S (664.4961)

(1r,3r)-3-hydroxy-1-[(2r,5r)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]-15-[(5s)-5-methyl-2-oxo-5h-furan-3-yl]-13-oxopentadecyl acetate

C39H68O8 (664.4914)